歡迎來到上海通蔚!

021-54845833/15800441009

品質(zhì)保證 · 通蔚試劑

當前位置: 首頁 > 科研產(chǎn)品 > 科研抗體 > 一抗 > 兔抗CTSF多克隆抗體

產(chǎn)品中心

  • 兔抗CTSF多克隆抗體

    規(guī)格:
    數(shù)量:

    購買數(shù)量

    價格:
    • 品牌 : 通蔚生物
    • 目錄號 : TW16272
    • 應(yīng)用 : 僅供科研使用
    • 保存條件 : 低溫保存
    • 貨期 : 現(xiàn)貨
    • 商品庫存:75
  • 商品詳情
  • 參考文獻
  • 說明書下載
  • 商品評論0
  • 相關(guān)產(chǎn)品


中文名稱:兔抗CTSF多克隆抗體  

英文名稱: Anti-CTSF rabbit polyclonal antibody

別      名: cathepsin F; CATSF; CLN13

相關(guān)類別: 一抗

儲      存: 冷凍(-20℃)

宿      主: Rabbit

抗      原: CTSF

反應(yīng)種屬: Human, Mouse

標 記  物: Unconjugate

克隆類型: rabbit polyclonal

技術(shù)規(guī)格

Background:

Cathepsins are papain family cysteine proteinases that represent a major component of the lysosomal proteolytic system. Cathepsins generally contain a signal sequence, followed by a propeptide and then a catalytically active mature region. The very long (251 amino acid residues) proregion of the cathepsin F precursor contains a C-terminal domain similar to the pro-segment of cathepsin L-like enzymes, a 50-residue flexible linker peptide, and an N-terminal domain predicted to adopt a cystatin-like fold. The cathepsin F proregion is unique within the papain family cysteine proteases in that it contains this additional N-terminal segment predicted to share structural similarities with cysteine protease inhibitors of the cystatin superfamily. This cystatin-like domain contains some of the elements known to be important for inhibitory activity. CTSF encodes a predicted protein of 484 amino acids which contains a 19 residue signal peptide. Cathepsin F contains five potential N-glycosylation sites, and it may be targeted to the endosomal/lysosomal compartment via the mannose 6-phosphate receptor pathway. The cathepsin F gene is ubiquitously expressed, and it maps to chromosome 11q13, close to the gene encoding cathepsin W.

Applications:

ELISA, IHC

Name of antibody:

CTSF

Immunogen:

Synthetic peptide of human CTSF

Full name:

cathepsin F

Synonyms:

CATSF; CLN13

SwissProt:

Q9UBX1

ELISA Recommended dilution:

5000-10000

IHC positive control:

Human colorectal cancer and human liver cancer

IHC Recommend dilution:

20-100